Pharmacokinetics, Tissue Distribution and Excretion of Verticinone from F. hupehensis in Rats
Xiao Wu,
Jian-Guo Sun,
Ying Peng,
Yan Liang,
Guang-Ji Wang,
Hui Chen,
Ji-Zhou Wu,
Peng Zhang
Affiliations
Xiao Wu
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy of Tongji Medical College, Huazhong University of Science and Technology, 13# Hangkong Road, Wuhan 430030, China
Jian-Guo Sun
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, 24# Tongjiaxiang, Nanjing 210009, China
Ying Peng
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, 24# Tongjiaxiang, Nanjing 210009, China
Yan Liang
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, 24# Tongjiaxiang, Nanjing 210009, China
Guang-Ji Wang
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, 24# Tongjiaxiang, Nanjing 210009, China
Hui Chen
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy of Tongji Medical College, Huazhong University of Science and Technology, 13# Hangkong Road, Wuhan 430030, China
Ji-Zhou Wu
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy of Tongji Medical College, Huazhong University of Science and Technology, 13# Hangkong Road, Wuhan 430030, China
Peng Zhang
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy of Tongji Medical College, Huazhong University of Science and Technology, 13# Hangkong Road, Wuhan 430030, China
Verticinone, the main active component in F. hupehensis, exhibits potent antitussive and expectorant effects. Here, a LC-MS method was developed and applied to study the pharmacokinetics, tissue distribution and excretion of verticinone in rats, and its plasma protein binding in vitro. A significant gender difference in the pharmacokinetics of verticinone in rats was observed, as its absolute oral bioavailability in male and female rats was 45.8% and 2.74%, respectively. The relative bioavailability of verticinone was significantly lower in female rats as compared to male, following intragastrical (i.g.) and intravenous (i.v.) administration. After successive i.g. administration of verticinone, accumulation was observed in female rats but not in the male ones. The tissue distribution study showed that verticinone had a good tissue penetrability and a high tissue affinity in most studied tissues, except brain. After a 2 mg/kg oral dose, less than 4% of the dose was excreted as unchanged parent compound in male rats, and less than 1% in female rats, which indicated that verticinone was metabolized more extensively in female rats than in male rats.
